Charles River Laboratories International, Inc. (CRL): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2017-12-30, while the company's latest annual report covers the year ended 2025-12-27. Its later filings do not report this line under the concept TickerFacts maps.

$289.67M
Year ended 2017-12-30
+2.8%
3-year compound annual growth
+2.4%
5-year compound annual growth
2008-12-27: $252.94M2009-12-26: $255.68M2010-12-25: $252.96M2011-12-31: $267.97M2012-12-29: $257.71M2013-12-28: $272.75M2014-12-27: $266.42M2015-12-26: $263.98M2016-12-31: $277.03M2017-12-30: $289.67M$289.67M
2008-12-27 Cost of Revenue (USD) 2017-12-30
Period endedCost of RevenueChange YoYSource filing
2017-12-30$289.67M+4.6%2018-02-13, From 2017-01-01
2016-12-31$277.03M+4.9%2018-02-13, From 2015-12-27
2015-12-26$263.98M-0.9%2018-02-13, From 2014-12-28
2014-12-27$266.42M-2.3%2017-02-14, From 2013-12-29
2013-12-28$272.75M+5.8%2016-02-12, From 2012-12-30
2012-12-29$257.71M-3.8%2015-02-17, From 2012-01-01
2011-12-31$267.97M+5.9%2014-02-25, From 2010-12-26
2010-12-25$252.96M-1.1%2013-02-27, From 2009-12-27
2009-12-26$255.68M+1.1%2012-02-27, From 2008-12-28
2008-12-27$252.94Mn/a2011-02-23, From 2007-12-30